(Q27124875)
Statements
1 reference
1 February 2021
1 reference
1 February 2021
1 reference
1 February 2021
1 reference
1 February 2021
1 reference
1 February 2021
1 reference
1 February 2021
1 reference
1 February 2021
1 reference
1 February 2021
1 reference
1 February 2021
1 reference
1 February 2021
1 reference
1 February 2021
1 reference
1 February 2021
1 reference
1 February 2021
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
CC(=O)NC1C(C(C(OC1OP(=O)([O-])OP(=O)([O-])OCC2C(C(C(O2)N3C=CC(=O)NC3=O)O)O)CO)O)O
1 reference
UDP-N-acetyl-alpha-D-glucosamine (English)
6 October 2016
CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OP(=O)([O-])OP(=O)([O-])OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O)CO)O)O
1 reference
UDP-N-acetyl-alpha-D-glucosamine (English)
6 October 2016
Identifiers
1 reference
UDP-N-acetyl-alpha-D-glucosamine (English)
6 October 2016
2 references
UDP-N-acetyl-alpha-D-glucosamine (English)
6 October 2016
1 reference
[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-oxido-phosphoryl] phosphate (English)
6 October 2016
2 references
UDP-N-acetyl-alpha-D-glucosamine (English)
6 October 2016
2 references